Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07674277 · ClinicalTrials.gov registry record · NA
Virtual Reality for SCD VOC
A NA study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07674277 is a NA study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 25 participants.
The verdict
NCT07674277, a NA study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This pilot study will evaluate the feasibility, tolerability, and preliminary analgesic effect of headset-based virtual reality interventions for adults with sickle cell disease experiencing vaso-occlusive crisis treated in an infusion center. Participants will be enrolled during routine outpatient sickle cell clinic visits and may receive study interventions during future qualifying infusion center visits for vaso-occlusive pain. Using a randomized, two-period crossover design, each participant will be assigned to receive two of three headset-based conditions across separate visits: sham 2D headset control, passive immersive 3D virtual reality, or active immersive interactive 3D virtual reality. The primary outcome is pain burden during the first 60 minutes after intervention start, measured as area under the curve of 0-10 numeric rating scale pain scores. Secondary outcomes include feasibility of intervention delivery, headset tolerability, pain at 120 minutes, opioid use, and participant-reported immersion and acceptability.
Interventions
- DEVICE Sham 2D Headset Control
- DEVICE Passive Immersive 3D Virtual Reality
- DEVICE Active Immersive Interactive 3D Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07674277
The ClinicalTrials.gov registry entry for NCT07674277 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham 2D Headset Control is the first listed.
NCT07674277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07674277 about?
NCT07674277 is a clinical study titled "Virtual Reality for SCD VOC". This pilot study will evaluate the feasibility, tolerability, and preliminary analgesic effect of headset-based virtual reality interventions for adults with sickle cell disease experiencing vaso-occlusive crisis treated in an infusion center. Participants will be enrolled during routine outpatient ...
What is the current status of trial NCT07674277?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-08-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07674277?
The interventions under investigation include: Sham 2D Headset Control (DEVICE), Passive Immersive 3D Virtual Reality (DEVICE), Active Immersive Interactive 3D Virtual Reality (DEVICE).
Who is sponsoring clinical trial NCT07674277?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.